287 related articles for article (PubMed ID: 24824295)
41. Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress.
Undas A; Szułdrzynski K; Stepien E; Zalewski J; Godlewski J; Tracz W; Pasowicz M; Zmudka K
Atherosclerosis; 2008 Feb; 196(2):551-7. PubMed ID: 17640649
[TBL] [Abstract][Full Text] [Related]
42. FIBTEM PLUS provides an improved thromboelastometry test for measurement of fibrin-based clot quality in cardiac surgery patients.
Solomon C; Baryshnikova E; Schlimp CJ; Schöchl H; Asmis LM; Ranucci M
Anesth Analg; 2013 Nov; 117(5):1054-62. PubMed ID: 24108255
[TBL] [Abstract][Full Text] [Related]
43. Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood.
Tutwiler V; Litvinov RI; Lozhkin AP; Peshkova AD; Lebedeva T; Ataullakhanov FI; Spiller KL; Cines DB; Weisel JW
Blood; 2016 Jan; 127(1):149-59. PubMed ID: 26603837
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of coagulation kinetics using thromboelastometry-methodologic influence of activator and test medium.
Sørensen B; Fenger-Eriksen C; Christiansen K; Larsen OH; Ingerslev J
Ann Hematol; 2010 Nov; 89(11):1155-61. PubMed ID: 20480163
[TBL] [Abstract][Full Text] [Related]
45. The electrolytic resistance of the blood clot in polycythemia vera before and after radiation and its relationship to clot retraction.
HENSTELL HH; HENSTELL IS; ORNITZ EM
Am J Clin Pathol; 1951 Sep; 21(9):820-7. PubMed ID: 14877772
[No Abstract] [Full Text] [Related]
46. Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.
Ostrowski SR; Berg RM; Windeløv NA; Meyer MA; Plovsing RR; Møller K; Johansson PI
PLoS One; 2013; 8(3):e59368. PubMed ID: 23555024
[TBL] [Abstract][Full Text] [Related]
47. [Large volume, isovolemic erythrocytapheresis in treatment of polycythemia vera. Effect of massive iron depletion of proliferation behavior of erythroid precursor cells (BFU-E)].
Liersch T; Vehmeyer K; Kaboth U
Med Klin (Munich); 1995 Jul; 90(7):390-7. PubMed ID: 7675003
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis.
Parra Salinas I; Recasens Flores V; Montañés MÁ; García-Erce JA
Med Clin (Barc); 2020 Jan; 154(1):16-19. PubMed ID: 30795904
[TBL] [Abstract][Full Text] [Related]
49. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
Gronostaj K; Richter P; Nowak W; Undas A
Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
[TBL] [Abstract][Full Text] [Related]
50. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
[TBL] [Abstract][Full Text] [Related]
51. Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication.
Bhasin N; Ariëns RA; West RM; Parry DJ; Grant PJ; Scott DJ
J Vasc Surg; 2008 Dec; 48(6):1497-503, 1503.e1. PubMed ID: 18829228
[TBL] [Abstract][Full Text] [Related]
52. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
Carr ME; Zekert SL
Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
[TBL] [Abstract][Full Text] [Related]
53. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
54. [Blood rheologic disorders in patients with polycythemia vera and their correction by therapeutic erythrocytapheresis].
Likhovetskaia ZM; Prigozhina TA; Gorbunova NA; Kalinin NN; Petrov MM
Gematol Transfuziol; 1989 Nov; 34(11):33-6. PubMed ID: 2612862
[TBL] [Abstract][Full Text] [Related]
55. The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
Anesth Analg; 2012 Jul; 115(1):16-21. PubMed ID: 22467887
[TBL] [Abstract][Full Text] [Related]
56. Similarities in thromboelastometric (ROTEM®) findings between humans and baboons.
Schöchl H; Solomon C; Laux V; Heitmeier S; Bahrami S; Redl H
Thromb Res; 2012 Sep; 130(3):e107-12. PubMed ID: 22482831
[TBL] [Abstract][Full Text] [Related]
57. In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
Theusinger OM; Baulig W; Asmis LM; Seifert B; Spahn DR
Thromb Haemost; 2010 Aug; 104(2):385-91. PubMed ID: 20431856
[TBL] [Abstract][Full Text] [Related]
58. Perioperative thromboelastography and sonoclot analysis in morbidly obese patients.
Pivalizza EG; Pivalizza PJ; Weavind LM
Can J Anaesth; 1997 Sep; 44(9):942-5. PubMed ID: 9305557
[TBL] [Abstract][Full Text] [Related]
59. Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxaban.
Varin R; Mirshahi S; Mirshahi P; Klein C; Jamshedov J; Chidiac J; Perzborn E; Mirshahi M; Soria C; Soria J
Thromb Res; 2013 Mar; 131(3):e100-9. PubMed ID: 23313382
[TBL] [Abstract][Full Text] [Related]
60. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Carr ME
Haemophilia; 2007 Sep; 13(5):533-41. PubMed ID: 17880440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
